The Gastric Cancer Foundation: A Gastric Cancer Registry
NCT01514045 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-05-18
Summary
The Gastric Cancer Registry will combine data acquired directly from patients with gastric cancer; with a family history of gastric cancer in a first or second degree relative; or persons with a known germline mutation in their CDH1 (E-Cadherin) gene via an online questionnaire with genomic data obtained from saliva, blood and tissue samples. The purpose of this registry is to gain better understanding of the causes of gastric cancer, both environmental and genetic; whether certain genomic data can predict outcomes of treatment and survival.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Hanlee P Ji, MD · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Transcriptomic Signatures in Gastric Adenocarcinoma
NCT05319392 ·Status: UNKNOWN
-
Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer
NCT02305043 ·Status: COMPLETED
-
Genomic Evolution of Metastasis in Gastric Cancer
NCT05061082 ·Status: UNKNOWN
-
Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer
NCT05140746 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer
NCT00675194 ·Status: COMPLETED ·Phase: PHASE2
-
Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis
NCT06109805 ·Status: COMPLETED
-
Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study
NCT01558011 ·Status: TERMINATED ·Phase: PHASE2
-
Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer
NCT06478394 ·Status: RECRUITING
-
Qualitative Research for Stage 4 Stomach Cancer and Their Caregivers
NCT01549756 ·Status: UNKNOWN
-
Artificial Intelligence and Cancer Staging in Upper Gastrointestinal Malignancies
NCT05648084 ·Status: COMPLETED
-
Resistance to Immunotherapy in Gastric Cancer
NCT03614013 ·Status: UNKNOWN
-
Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric Cancer
NCT04086888 ·Status: UNKNOWN
-
A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression
NCT02005484 ·Status: TERMINATED ·Phase: PHASE2
-
Methylation Analysis of Circulating Tumor DNA in Gastric Cancer
NCT04511559 ·Status: UNKNOWN
-
Microbiota and Metabolomics of Intestinal Type of Gastric Cancer
NCT06079554 ·Status: RECRUITING
-
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
NCT00515216 ·Status: COMPLETED ·Phase: PHASE2
-
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
NCT06727981 ·Status: RECRUITING
-
the Optimal Surveillance Frequency for Stage II/III Gastric Cancer
NCT05465993 ·Status: COMPLETED
-
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
NCT00780494 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer
NCT06408220 ·Status: RECRUITING ·Phase: NA
-
Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial
NCT06943794 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology
NCT03092518 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting Biomarker of Gastric Cancer Chemotherapy Response
NCT03253107 ·Status: RECRUITING
-
The Expression of ZEB1 in CTCs Associated With Metastasis and Recurrence for Gastric Cancer
NCT02431078 ·Status: UNKNOWN
-
The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study
NCT02583659 ·Status: UNKNOWN